UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors

Chinese medical journal, 2022-06, Vol.135 (12), p.1404-1413

2022

Volltextzugriff (PDF)

18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients

European journal of nuclear medicine and molecular imaging, 2020-05, Vol.47 (5), p.1116-1126

2020

Volltextzugriff (PDF)

Laccase-mediator co-immobilized doped-HKUST-1 cellulose composite beads and their application for the biodegradation of carbazole

Reaction chemistry & engineering, 2023-08, Vol.8 (9), p.2342-2352

2023

Volltextzugriff (PDF)

Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

BMC cancer, 2019-04, Vol.19 (1), p.369-369, Article 369

2019

Volltextzugriff (PDF)

Genomic Characterization of ERBB2 -Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine

JCO precision oncology, 2019-12 (3), p.1-9

2019

Volltextzugriff (PDF)

Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors? - A literature-based meta-analysis

Journal of hematology and oncology, 2012-10, Vol.5 (1), p.62-62, Article 62

2012

Volltextzugriff (PDF)

Deep degradation of atrazine in water using co-immobilized laccase-1-hydroxybenzotriazole-Pd as composite biocatalyst

Journal of hazardous materials, 2024-04, Vol.468, p.133779, Article 133779

2024

Volltextzugriff (PDF)

A novel bio-photocatalytic system for efficient degradation of indole by Bi2WO6-Ni-DA@HRP photoperoxidase microspheres

Biochemical engineering journal, 2024-09, Vol.209, p.109381, Article 109381

2024

Volltextzugriff (PDF)

Visible-light-driven photo-peroxidase catalysis: high-efficiency degradation of indole in water

RSC advances, 2024-02, Vol.14 (1), p.6874-6882

2024

Volltextzugriff (PDF)

Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer

European radiology, 2019-06, Vol.29 (6), p.2958-2967

2019

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA)-based minimal residual disease in non-small cell lung cancer

Chinese Medical Journal - Pulmonary and Critical Care Medicine, 2023-12, Vol.1 (4), p.207-214

2023

Volltextzugriff (PDF)

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer discovery, 2020-05, Vol.10 (5), p.674-687

2020

Volltextzugriff (PDF)

Molecular characteristics and treatment strategy in advanced, EGFR-mutant non-small cell lung cancer with concomitant BRAF variations

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21021-e21021

2022

Volltextzugriff (PDF)

Adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A single center, real-world study in China

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21081-e21081

2021

Volltextzugriff (PDF)

Patient-derived organoids to predict the drug response in locally advanced or metastatic lung cancer: A real-world study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9136-9136

2022

Volltextzugriff (PDF)

Automated PET/CT radiomic analysis with machine learning for identifying bone marrow involvement in the patients with suspected relapsed acute leukemia

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

Journal of thoracic oncology, 2024-08

2024

Volltextzugriff (PDF)

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

Journal of thoracic oncology, 2024-08

2024

Volltextzugriff (PDF)

Familial association of lung cancer patients with liver cancer in first-degree relatives

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13597-e13597

2018

Volltextzugriff (PDF)

A dedicated lung cancer immunotherapy outpatient clinic: The first experience in China

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e14022-e14022

2020

Volltextzugriff (PDF)

Safety of nivolumab/pembrolizumab in hepatitis B surface antigen-positive non-small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21670-e21670

2020

Volltextzugriff (PDF)

Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions

Lung cancer (Amsterdam, Netherlands), 2021-09, Vol.159, p.66-73

2021

Volltextzugriff (PDF)

Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors

Future oncology (London, England), 2022-06, Vol.18 (17), p.2053-2062

2022

Volltextzugriff (PDF)

Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9078-9078

2019

Volltextzugriff (PDF)

Liquid biopsy guided precision therapy for lung cancers

Journal of thoracic disease, 2018-11, Vol.10 (Suppl 33), p.S4173-S4175

2018

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)
Tagungsberichte
(2)

Sprache

Englisch
(58)
Chinesisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(16)
Humans
(14)
Male
(9)
Oncology
(9)
Middle Aged
(7)
Lung Cancer
(6)
Physical Sciences
(6)
Aged
(5)
Chemotherapy
(5)
Female
(5)
Mutation
(5)
Non-Small Cell Lung Cancer
(5)
Patients
(5)
Technology
(5)
Treatment Outcome
(5)
Adult
(4)
Carcinoma, Non-Small-Cell Lung - Genetics
(4)
Engineering
(4)
Feature Extraction
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors

18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients

Laccase-mediator co-immobilized doped-HKUST-1 cellulose composite beads and their application for the biodegradation of carbazole

Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

Genomic Characterization of ERBB2 -Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine

Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors? - A literature-based meta-analysis

Deep degradation of atrazine in water using co-immobilized laccase-1-hydroxybenzotriazole-Pd as composite biocatalyst

A novel bio-photocatalytic system for efficient degradation of indole by Bi2WO6-Ni-DA@HRP photoperoxidase microspheres

Visible-light-driven photo-peroxidase catalysis: high-efficiency degradation of indole in water

Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer

Circulating tumor DNA (ctDNA)-based minimal residual disease in non-small cell lung cancer

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Molecular characteristics and treatment strategy in advanced, EGFR-mutant non-small cell lung cancer with concomitant BRAF variations

Adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A single center, real-world study in China

Patient-derived organoids to predict the drug response in locally advanced or metastatic lung cancer: A real-world study

Automated PET/CT radiomic analysis with machine learning for identifying bone marrow involvement in the patients with suspected relapsed acute leukemia

Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

Familial association of lung cancer patients with liver cancer in first-degree relatives

A dedicated lung cancer immunotherapy outpatient clinic: The first experience in China

Safety of nivolumab/pembrolizumab in hepatitis B surface antigen-positive non-small cell lung cancer (NSCLC) patients

Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions

Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors

Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers

Liquid biopsy guided precision therapy for lung cancers

Suchergebnisse filtern